| View |
|
BRP-072
|
Botulinum Toxin Type A (from clostridium botulinum)
|
Nabota
|
50 units
|
Lyophilized Powder For Injection (IM/SC)
|
Muscle Relaxant
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
Automatic Renewal
|
29 July 2022
|
17 August 2027
|
| View |
|
BRP-074-01
|
Insulin Human (rDNA)
|
Lupinsulin 30:70
|
100 IU/mL Suspension for Injection (IM/SC) (30% Soluble Insulin Human / 70% Isophane Insulin
Human)
|
Suspension for Injection (IM/SC)
|
Antidiabetic agents
|
M.J. Biopharm Pvt., Ltd.
|
India
|
Renewal
|
05 May 2022
|
23 February 2027
|
| View |
|
BRP-075
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Aropotin
|
2000 IU/ 0.5 mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
HK Bioinnovation Co., Ltd
|
Korea
|
Renewal
|
23 July 2021
|
23 August 2026
|
| View |
|
BRP-076-01
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Epolitt
|
4,000 IU
|
Solution For Injection
|
-
|
TS Corporation
|
Korea
|
Renewal
|
21 September 2021
|
23 August 2026
|
| View |
|
BRP-076-02
|
Epoetin Alfa
|
Eprotex
|
4000 IU / 0.5mL
|
Solution For Injection(IV/SC)
|
Hematopoietic Growth Factors
|
HK Bioinnovation Co., Ltd
|
Korea
|
Compliance - RNW
|
29 March 2022
|
23 August 2026
|
| View |
|
BRP-076-03
|
Epoetin Alfa
|
Eprosenz
|
4000 IU/0.5mL
|
Solution For Injection (IV/SC)
|
Hematopoietic Growth Factors
|
HK Bioinnovation Co., Ltd
|
Korea
|
Compliance - RNW
|
29 March 2022
|
23 August 2026
|
| View |
|
BRP-076-04
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Ematep
|
4000 IU/0.5 mL
|
Solution For Injection (Iv/Sc)
|
-
|
TS Corporation
|
Korea
|
Renewal
|
17 September 2021
|
23 August 2026
|
| View |
|
BRP-083
|
Rituximab
|
Truxima
|
500mg
|
Concentrate for Solution for Infusion
(IV)
|
-
|
Celltrion Incorporated (Plant 2)
|
Korea
|
Renewal
|
06 July 2023
|
13 June 2028
|
| View |
|
BRP-085
|
Heparin Sodium
|
Bruhep
|
1,000 IU/Ml
|
Solution for Injection (IV/SC)
|
Antithrombotic agents
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
17 January 2023
|
11 October 2028
|
| View |
|
BRP-085-01
|
Heparin Sodium
|
Cenprahep
|
1000 IU/mL
|
Solution For Injection (IV/SC)
|
Antithrombotic agents
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
07 March 2023
|
11 October 2028
|
| View |
|
BRP-086
|
Human Normal Immunoglobulin
|
Bioven Mono
|
50mg/Ml (5% w/v)
|
Solution For Injection (I.V.)
|
Immunoglobulin
|
Biofarma Plasma Limited Liability Company
|
Ukraine
|
Renewal
|
05 December 2023
|
29 May 2029
|
| View |
|
BRP-090
|
Equine Anti-Rabies Immunoglobulin
|
Vinrab
|
200 IU/mL (1000 IU/5mL)
|
Solution For Injection I.M
|
Immunoglobulins
|
Vins Bioproducts, Ltd.
|
India
|
Renewal
|
21 March 2024
|
16 March 2029
|
| View |
|
DR-721
|
Balanced Multiple Maintenance Solution With 5% Dextrose (See formulation on reverse side)
|
Multisol-M In D5 Water
|
Each 100 mL contains 5 g Dextrose Monohydrate; 234 mg Sodium Chloride; 128 mg Potassium Acetate; 21 mg Magnesium Acetate & 30 mg Sodium Metabisulfite
|
Solution For Iv Infusion
|
Electrolyte Replenisher
|
Euro-Med Laboratories Phil., Inc
|
Philippines
|
Automatic Renewal
|
03 September 2020
|
16 October 2025
|
| View |
|
DR-10073
|
Clobetasol Propionate
|
Dermovate
|
500 mcg/g
|
Ointment
|
Corticosteroid
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Initial
|
15 June 2023
|
15 June 2028
|
| View |
|
DR-10074
|
Clobetasol Propionate
|
Dermovate
|
500 mcg/g
|
Cream
|
-
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Initial
|
18 January 2023
|
18 January 2028
|
| View |
DR-10256_PI_01.pdf
|
DR-10256
|
Prednisolone (as acetate)
|
Pred Forte
|
|
Sterile Suspension (Opthalmic Drops)
|
Anti-Inflammatory (Steroidal)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
13 January 2022
|
03 March 2027
|
| View |
|
DR-1110
|
Furosemide
|
Lasix
|
40 mg
|
Tablet
|
Diuretic
|
Handok Inc.
|
Korea
|
Automatic Renewal
|
07 March 2023
|
15 April 2028
|
| View |
|
DR-1111
|
Furosemide (as sodium)
|
Lasix
|
10 mg/mL (20 mg/2 mL)
|
Solution For Injection (IV/IM)
|
Diuretic (Sulfonamide)
|
Delpharm Dijon
|
France
|
Renewal
|
02 March 2025
|
05 November 2026
|
| View |
DR-1168_PI_01.pdf
|
DR-1168
|
Sodium Fusidate
|
FUCIDIN
|
250 mg
|
Film-Coated Tablet
|
Antibacterial
|
Laboratories LEO S.A.
|
France
|
Renewal
|
25 July 2024
|
23 October 2029
|
| View |
DR-1170_PIL_01.pdf
|
DR-1170
|
Sodium Fusidate
|
Fucidin
|
20mg/ g
|
Ointment
|
Antibacterial
|
Leo Laboratories Ltd.
|
Ireland
|
Renewal
|
21 October 2024
|
27 March 2030
|